• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.肝星状细胞中SOCS1表达对高脂饮食诱导的肝纤维化的调控
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101280. doi: 10.1016/j.jceh.2023.09.001. Epub 2023 Sep 9.
2
Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis.SOCS1 在控制肝纤维化过程中肝星状细胞固有作用及肝纤维化时促炎性巨噬细胞区室。
Front Immunol. 2023 Oct 4;14:1259246. doi: 10.3389/fimmu.2023.1259246. eCollection 2023.
3
Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis.细胞因子信号转导抑制因子 1(SOCS1)在肝细胞和巨噬细胞中对肝纤维化调节的重要作用。
Cytokine. 2019 Dec;124:154501. doi: 10.1016/j.cyto.2018.07.032. Epub 2018 Aug 8.
4
Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.细胞因子信号转导抑制因子1对肝脏纤维化反应的负调控
Cytokine. 2016 Jun;82:58-69. doi: 10.1016/j.cyto.2015.12.007. Epub 2015 Dec 31.
5
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.STING 在非酒精性脂肪性肝病患者的肝组织中表达增加,并促进小鼠巨噬细胞介导的肝炎症和纤维化。
Gastroenterology. 2018 Dec;155(6):1971-1984.e4. doi: 10.1053/j.gastro.2018.09.010. Epub 2018 Sep 10.
6
Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.组织蛋白酶 3 样蛋白 1 基因在骨髓细胞中特异性缺失可改善小鼠饮食诱导的脂肪性肝炎进展。
J Mol Med (Berl). 2023 Jul;101(7):813-828. doi: 10.1007/s00109-023-02325-4. Epub 2023 May 11.
7
Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.肝星状细胞特异性 LOXL1 缺乏可消除非肥胖 NASH 小鼠的肝炎症、肝纤维化,并纠正脂质代谢异常。
Hepatol Int. 2021 Oct;15(5):1122-1135. doi: 10.1007/s12072-021-10210-w. Epub 2021 May 20.
8
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
9
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.阿伐麦布下调肝星状细胞中的硬脂酰辅酶A去饱和酶1,以减轻细胞纤维化。
JHEP Rep. 2021 Jan 28;3(3):100237. doi: 10.1016/j.jhepr.2021.100237. eCollection 2021 Jun.
10
NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis.NLRC5 缺乏可使肝脏炎症反应失调,但不会加重四氯化碳诱导的肝纤维化。
Front Immunol. 2021 Oct 12;12:749646. doi: 10.3389/fimmu.2021.749646. eCollection 2021.

引用本文的文献

1
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems.肝脏脂蛋白代谢:当前和未来基于细胞的体外系统
Biomolecules. 2025 Jul 2;15(7):956. doi: 10.3390/biom15070956.
2
Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease.开发SOCS1模拟物作为协调代谢功能障碍相关脂肪性肝病中炎症、氧化应激和纤维化形成的新方法。
Redox Biol. 2025 Jul;84:103670. doi: 10.1016/j.redox.2025.103670. Epub 2025 May 11.
3
Baicalin mitigates alcoholic-associated liver disease via SOCS1-driven reprogramming of macrophages.黄芩苷通过SOCS1驱动的巨噬细胞重编程减轻酒精相关性肝病。
Chin Med. 2025 May 13;20(1):63. doi: 10.1186/s13020-025-01110-4.
4
EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure.高脂肪饮食暴露诱导的小鼠肝脏中 EZH2 介导的 H3K27 三甲基化是早期的表观遗传事件。
Nutrients. 2024 Sep 26;16(19):3260. doi: 10.3390/nu16193260.
5
SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.SOCS1 在癌细胞中的表达:在促进抗肿瘤免疫中的潜在作用。
Front Immunol. 2024 Feb 13;15:1362224. doi: 10.3389/fimmu.2024.1362224. eCollection 2024.

本文引用的文献

1
An inducible model for genetic manipulation and fate-tracing of PDGFRβ-expressing fibrogenic cells in the liver.一种诱导型模型,用于遗传操作和肝内 PDGFRβ 表达纤维生成细胞的命运追踪。
Sci Rep. 2023 May 5;13(1):7322. doi: 10.1038/s41598-023-34353-y.
2
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease.肝星状细胞:在非酒精性脂肪性肝病中决定结局。
Cell Mol Gastroenterol Hepatol. 2023;15(6):1277-1292. doi: 10.1016/j.jcmgh.2023.02.010. Epub 2023 Feb 23.
3
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties.非酒精性脂肪性肝病的医疗保健和社会经济学成本:一个应对不确定性的全球框架。
J Hepatol. 2023 Jul;79(1):209-217. doi: 10.1016/j.jhep.2023.01.026. Epub 2023 Feb 4.
4
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.肝星状细胞亚群在肝癌发生中的相反作用。
Nature. 2022 Oct;610(7931):356-365. doi: 10.1038/s41586-022-05289-6. Epub 2022 Oct 5.
5
An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues.一种从脂肪性和纤维化肝组织中分离肝内白细胞并进行流式细胞术表征的改进方法。
Anat Rec (Hoboken). 2023 May;306(5):1011-1030. doi: 10.1002/ar.25039. Epub 2022 Jul 18.
6
Hepatic Stellate Cell-Immune Interactions in NASH.非酒精性脂肪性肝炎中肝星状细胞-免疫相互作用。
Front Endocrinol (Lausanne). 2022 Jun 9;13:867940. doi: 10.3389/fendo.2022.867940. eCollection 2022.
7
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future.2022 年肝脏纤维化:未满足的需求和未来蓝图。
Hepatology. 2022 Feb;75(2):473-488. doi: 10.1002/hep.32285. Epub 2022 Jan 11.
8
New targets for NAFLD.非酒精性脂肪性肝病的新靶点
JHEP Rep. 2021 Aug 8;3(6):100346. doi: 10.1016/j.jhepr.2021.100346. eCollection 2021 Dec.
9
Mechanisms and disease consequences of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的机制及疾病后果
Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.
10
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?非酒精性脂肪性肝炎-肝纤维化中肝星状细胞的激活与失活——作为潜在治疗靶点的作用?
Biomedicines. 2021 Mar 31;9(4):365. doi: 10.3390/biomedicines9040365.

肝星状细胞中SOCS1表达对高脂饮食诱导的肝纤维化的调控

Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.

作者信息

Kandhi Rajani, Menendez Alfredo, Ramanathan Sheela, Ilangumaran Subburaj

机构信息

Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.

Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.

出版信息

J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101280. doi: 10.1016/j.jceh.2023.09.001. Epub 2023 Sep 9.

DOI:10.1016/j.jceh.2023.09.001
PMID:38076369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10709186/
Abstract

BACKGROUND

Hepatic stellate cells (HSC) are the key mediators of fibrosis development in non-alcoholic fatty liver disease (NAFLD). Hepatic inflammation induced by high-fat diet activates HSCs, which differentiate to myofibroblasts and produce extracellular fibrillar matrix. HSC activation during hepatic fibrogenesis is modulated by cytokines and growth factors produced by stressed hepatocytes and macrophages. SOCS1 is a negative feedback regulator of certain cytokines and growth factors implicated in liver fibrosis.

AIM

The goal of this study was to understand the regulatory functions of SOCS1 in HSCs during NAFLD-induced liver fibrosis.

METHODOLOGY

Mice lacking SOCS1 specifically in HSCs () and control -floxed () mice were fed choline-deficient L-amino acid-defined high-fat diet (CDA-HFD) or normal control diet for 14 weeks. Body weight gain was regularly monitored. Serum alanine aminotransferase levels and liver weight were assessed at the endpoint. Fibrosis development was evaluated by Sirius red staining and hydroxyproline content, and myofibroblast differentiation by immunohistochemistry. Expression of genes encoding pro-fibrogenic factors, cytokines, growth factors and chemokines, and the phenotype and numbers of intrahepatic leukocytes were evaluated.

RESULTS

mice showed increased liver/body weight ratio and displayed increased collagen deposition and myofibroblast differentiation. Induction of , , , and genes was significantly elevated in mice compared to controls fed CDA-HFD. gene induction was comparable between the two groups, however, livers displayed increased SMAD3 phosphorylation. The fibrotic livers of mice showed increased inflammatory cell infiltration, and flow cytometry analysis revealed elevated numbers of myeloid cells, granulocytes and myeloid-derived dendritic cells. livers harbored increased numbers of Ly6CCCR2+ pro-inflammatory macrophages, largely comprised of Ly6CCCR2+CX3CR1+ cells, suggesting impaired transition to anti-inflammatory macrophages.

CONCLUSION

Our findings show that SOCS1 exerts non-redundant regulatory functions in HSCs that are critical for attenuating high-fat diet-induced inflammatory response and liver fibrosis development.

摘要

背景

肝星状细胞(HSC)是非酒精性脂肪性肝病(NAFLD)纤维化发展的关键介质。高脂饮食诱导的肝脏炎症激活HSC,其分化为肌成纤维细胞并产生细胞外纤维状基质。肝纤维化过程中HSC的激活受应激肝细胞和巨噬细胞产生的细胞因子和生长因子调节。SOCS1是与肝纤维化相关的某些细胞因子和生长因子的负反馈调节因子。

目的

本研究的目的是了解SOCS1在NAFLD诱导的肝纤维化过程中对HSC的调节功能。

方法

将HSC中特异性缺失SOCS1的小鼠( )和对照floxed小鼠( )喂食胆碱缺乏的L-氨基酸定义的高脂饮食(CDA-HFD)或正常对照饮食14周。定期监测体重增加。在实验终点评估血清丙氨酸转氨酶水平和肝脏重量。通过天狼星红染色和羟脯氨酸含量评估纤维化发展,通过免疫组织化学评估肌成纤维细胞分化。评估编码促纤维化因子、细胞因子、生长因子和趋化因子的基因表达,以及肝内白细胞的表型和数量。

结果

小鼠的肝/体重比增加,胶原沉积和肌成纤维细胞分化增加。与喂食CDA-HFD的 对照相比, 小鼠中 、 、 、 和 基因的诱导显著升高。两组之间 基因的诱导相当,然而, 小鼠肝脏中SMAD3磷酸化增加。 小鼠的纤维化肝脏显示炎症细胞浸润增加,流式细胞术分析显示髓样细胞、粒细胞和髓样来源的树突状细胞数量增加。 小鼠肝脏中Ly6C+CCR2+促炎巨噬细胞数量增加,主要由Ly6C+CCR2+CX3CR1+细胞组成,提示向抗炎巨噬细胞的转变受损。

结论

我们的研究结果表明,SOCS1在HSC中发挥非冗余的调节功能,这对于减轻高脂饮食诱导的炎症反应和肝纤维化发展至关重要。